Harrow

HROWNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.272 B

$33.92 +2.54%

Close of 21 Sept 2026

Revenue

$272.3M

#2175 by revenue

Earnings

-$5.14M

Loss-making

Shares outstanding

37,487,850

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#140OmerosOMER$1.34B
#141Oric PharmaceuticalsORIC$1.31B
#142HarrowHROW$1.27B
#143Opko HealthOPK$1.26B
#144Alto NeuroscienceANRO$1.20B

What if Harrow were worth as much as…

Open the what-if tool →

Gold $30.3T

$807,569.76

Per share 23,808× higher

Bitcoin $1.72T

$45,876.30

Per share 1,352× higher

Nvidia $5.48T

$146,176.91

Per share 4,309× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Harrow are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.